Company intelligence / Profile preview
SciClone Pharmaceuticals (Holdings) Limited
Shanghai, Shanghai, Chinasciclone.com ↗
- Ownership
- Public · HK:6600
- Employees
- ~1050
- Development stage
- Commercial
01
Overview
SciClone has a substantial revenue-generating commercial business with multiple marketed products. Their flagship product Zadaxin (thymalfasin) is used for treating hepatitis B, sepsis, and as part of cancer combination therapies. The company has eight early to late-stage investigational assets, with five in pivotal or later clinical trials. Recent clinical progress includes Phase 3 trials for ZADAXIN in sepsis and Phase 1 trials for PT-112 in advanced solid tumors.
- Therapeutic areas
- PulmonologyCardiovascularOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesdrug conjugatesimmunotherapeutics
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
04
Financials
- Market cap
- $356.9M
- Total revenue
- $48.6M
- Enterprise value
- $384.8M
Beyond the preview
Go deeper on SciClone Pharmaceuticals (Holdings) Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SciClone Pharmaceuticals (Holdings) Limited.